Downregulation of NFκB can also ameliorate kidney injury through the reduction of the glomerular NLRP3 inflammasome in diabetic nephropathy (DN), which has been demonstrated in experiments exploring the mechanism of pioglitazone in DN (104). The gene discussed is NLRP3; the disease is liver dysplastic nodule.